KAUST Smart-Health Initiative

We are proud to showcase outstanding smart health-related research supported by exceptional illustrations and 3D-modelizations.

Learn more about how can a new computer-aided diagnostic tool developed by KAUST scientists could help overcome some of the challenges of monitoring lung health following viral infection.

Research by Xin Gao, Professor, Computer Science and Longxi-Zhou, Ph.D. Student.

Read More

Latest news

25 August, 2022

Building applications inspired by the human eye

A team of researchers at the KAUST Sensors Lab, led by Professor Khaled Nabil Salama, is focused on developing brain-mimicking neuromorphic circuits to build efficient vision sensors.

Read more

24 August, 2022

"Sticky" stem cells make for better transplants

Enhancement of adhesion molecules improves the ability of blood-forming stem cells to take root in transplant recipients.

Read more

16 August, 2022

RNA-based approach identified for treatment of premature aging and associated diseases

KAUST scientists are researching RNA-based approaches to treat progeria, an early aging disease that affects children and adolescents.

Read more

Latest Events

Modern trends in targeted structure-based drug design and discovery

Molecular Diagnostics and Drug Discovery Lab (MD3) at King Abdullah University of Science and Technology (KAUST) along with KAUST Smart Health Initiative (SHI) are pleased to announce the KAUST Research Conference 2022 on drug design titled "Modern trends in targeted structure-based drug design and discovery."

As a mankind, we have been in a constant struggle with various diseases and plagues since our early days. Over the centuries we have been discovering remedies for vast array of health problems, however during the last decades we can observe a decline of groundbreaking discoveries in pharmaceutical industry due to increasing complexities in finding a specific ligand for the target of interest. As our knowledge on genome, proteome and metabolome have increased and the technology improved, hundreds of new and potential drug targets have surfaced. However, finding a ligand that could bind to the target of interest have proven to be a major decelerator in progress. To overcome this, structure-based approach in drug design have been extensively used and have already proven its efficacy.

The meeting will address the recent trends in contemporary drug design and discovery from the perspective of experimental state-of-the-art integrated structural biology and artificial intelligence AI-augmented computational solutions. The attendees will have an opportunity to gain and exchange knowledge on tools, resources, approaches and ideas with the world-renowned scientists and researchers in the field.